{"id":"placebo-for-flucloxacillin","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials and research settings. It works through expectation, conditioning, and the placebo effect rather than through direct molecular action. In this context, it was used as a comparator in a flucloxacillin study conducted by AMC-UvA.","oneSentence":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:56.524Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control comparator in clinical research (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT05584007","phase":"PHASE3","title":"Cellulitis Optimal Antibiotic Treatment","status":"RECRUITING","sponsor":"University of Southampton","startDate":"2023-08-29","conditions":"Cellulitis of Leg","enrollment":356},{"nctId":"NCT01876628","phase":"PHASE4","title":"Adjunctive Clindamycin for Cellulitis: C4C Trial.","status":"COMPLETED","sponsor":"University Hospitals Bristol and Weston NHS Foundation Trust","startDate":"2013-10","conditions":"Cellulitis","enrollment":410},{"nctId":"NCT02032654","phase":"PHASE4","title":"Duration of ANtibiotic Therapy for CEllulitis","status":"TERMINATED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-08-26","conditions":"Cellulitis, Erysipelas","enrollment":151},{"nctId":"NCT02922686","phase":"PHASE4","title":"Penicillin for the Emergency Department Outpatient Treatment of CELLulitis","status":"UNKNOWN","sponsor":"Royal College of Surgeons, Ireland","startDate":"2016-12","conditions":"Cellulitis, Wound Infection, Abscess","enrollment":414}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo (for flucloxacillin)","genericName":"Placebo (for flucloxacillin)","companyName":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","companyId":"academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control comparator in clinical research (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}